EBRC In Translation

1. Drug Discovery and Corporate Coup D'états w/ Sri Kosuri

February 03, 2021 EBRC SPA Episode 1
EBRC In Translation
1. Drug Discovery and Corporate Coup D'états w/ Sri Kosuri
Show Notes

In this episode, we interview Dr. Sri Kosuri, an Associate Professor at UCLA and the founder and CEO of Octant Bio. We talk to Dr. Kosuri about his career trajectory, starting in the earliest days of synthetic biology up to the present, where his team is using next-generation DNA synthesis and sequencing technologies to accelerate the discovery of new drugs for the treatment of complex diseases. Along the way we talk about wikis before Wikipedia, engineering vegetables that are arbitrary shapes, and questioning our most basic scientific assumptions.

For more information about EBRC, visit our website at ebrc.org. If you are interested in getting involved with the EBRC Student and Postdoc Association, fill out a membership application for graduate students and postdocs or for undergraduates and join today!